On heterogeneity of non-Hodgkin's lymphomas as regards sensitivity to cytostatic drugs. An in vitro study.
D002478:Cells, Cultured; D003561:Cytarabine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D011238:Prednimustine / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
D004273:DNA, Neoplasm; D003561:Cytarabine; D014750:Vincristine; D011238:Prednimustine; D008558:Melphalan; D013936:Thymidine